Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
Monthly Minutes
Breast Cancer-OFS Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
Monthly Minutes
Breast Cancer-OFS Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
November 2014, Vol 4, No 7
Where Did My Data Go?
By
Teri U. Guidi, MBA, FAAMA
Practice Management
November 2014, Vol 4, No 7
Read More ›
Influences on Rising Oncology Drug Costs
By
Ruth Linn Lander, FACMPE
November 2014, Vol 4, No 7
Read More ›
Taking a Deep Breath Before the Holidays
By
Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
November 2014, Vol 4, No 7
Read More ›
Tattletale or Whistleblower: What’s an Employer to Do?
By
Robert D. Orzechowski, MBA, SPHR, SHRM-SCP
Practice Management
November 2014, Vol 4, No 7
Read More ›
Do’s and Don’ts in Physician–Hospital Alignment, Part 3
By
Max Reiboldt, CPA
Practice Management
November 2014, Vol 4, No 7
Read More ›
Patient Portals Improve Healthcare, but Are Still Works in Progress
By
Chase Doyle
November 2014, Vol 4, No 7
Read More ›
Investing: Where to Put Your Money Now
By
Lawrence B. Keller, CFP, CLU, ChFC, RHU, LUTCF
;
W. Ben, Utley, CFP
Financial Management
,
Practice Management
November 2014, Vol 4, No 7
Read More ›
Recent Drug Approvals
FDA Approvals, News & Updates
November 2014, Vol 4, No 7
Read More ›
New Clinical Trials Under Way
Clinical Trials Tracker
November 2014, Vol 4, No 7
Read More ›
Beleodaq (Belinostat) Receives FDA Approval for the Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
By
Lisa A. Raedler, PhD, RPh
Drug Updates
November 2014, Vol 4, No 7
Read More ›
Page 1 of 2
1
2